Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Market Acceleration in the Gastric Ulcers Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Gastric Ulcers Market Size By 2025?
In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%. The historical growth of this market is credited to several factors including the increase in helicobacter pylori infections, the growing use of nonsteroidal anti-inflammatory drugs (NSAIDs), the rise in the elderly population worldwide, heightened gastric ulcer prevention awareness campaigns, and the escalating incidence of stress-induced conditions.

How Big Is the Gastric Ulcers Market Size Expected to Grow by 2029?
Expectations are high for robust expansion in the gastric ulcer market over the coming years. The market is projected to surge to $5.64 billion by 2029, with a compound annual growth rate (CAGR) of 5.5%. This anticipated increase for the forecast period can be credited to advancements in diagnostic methods, adoption of detrimental dietary patterns, progress in therapy options such as proton pump inhibitors (PPIs), the impact of an aging population on disease frequency, and healthcare infrastructure growth in developing markets. The forecast period is characterized by key trends including a shift towards combination therapies for improved effectiveness, a rising inclination for minimally invasive treatment methods, the incorporation of digital health solutions into disease care, an increasing requirement for over-the-counter (OTC) ulcer drugs, and the ongoing expansion of personalized medicine in ulcer treatment.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Which Key Market Drivers Powering Gastric Ulcers Market Expansion and Growth?
The growth of the gastric ulcers market is likely to be fueled by the mounting elderly population. Generally, the elderly population comprises people who are 65 years or older and have specific health needs due to aging. This rise in the number of elderly individuals is a product of healthcare advancements, leading to increased life expectancy, and declining birth rates across the globe. Gastric ulcers tend to be prevalent among the elderly, due to a high consumption of NSAIDs and reduced mucosal protection, resulting in an escalated risk of complications. For example, in January 2024, the Population Reference Bureau (PRB), a non-profit organization based in the U.S, predicted that the number of Americans aged 65 and older would surge from 58 million in 2022 to 82 million by 2050. This swell represents a 47% increase. The estimated rise in the population percentage of this age group, from 17% to 23%, points towards a significant aging trend in the American population. These predictions underscore the growing need to cater to the needs of the elderly. Hence, the escalating elderly population propels the growth of the gastric ulcers market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Gastric Ulcers Market?
Prominent enterprises in the gastric ulcer market are emphasizing innovation in their product offerings, such as the creation of novel drug formulations, with an objective of augmenting treatment effectiveness and mitigating side-effects. These new formulation drugs encompass inventive combinations of active constituents, delivery mechanisms, or dosage forms to enhance their efficacy, safety, and patient adherence. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., a pharmaceutical production company based in India, introduced Rabeprazole + Levosulpiride SR Capsules catering to ailments such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These newly launched products integrate a proton pump inhibitor and a prokinetic agent, offering effective treatment for gastrointestinal issues such as GERD and gastric ulcers. This unique formulation not only diminishes gastric acid production, but also improves gastric mobility, thus offering a comprehensive solution to symptoms like heartburn and digestion problems.

What Are the Emerging Segments in the Gastric Ulcers Market?
The gastric ulcers market covered in this report is segmented -

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes
2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:
1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole
2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate
4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline
5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate
6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

Who Are the Global Leaders in the Gastric Ulcers Market?
Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Which are the Top Profitable Regional Markets for the Gastric Ulcers Industry?
North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17160

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.